A multicenter, randomized, double-blind, double dummy, group-comparative trial to compare the effects of Livial [tibolone] and Activelle [Ethinylestradiol/norethisterone] on the vaginal bleeding pattern, vasomotor complaints, vaginal atrophy, QoL [quality of life] and sexual function

Trial Profile

A multicenter, randomized, double-blind, double dummy, group-comparative trial to compare the effects of Livial [tibolone] and Activelle [Ethinylestradiol/norethisterone] on the vaginal bleeding pattern, vasomotor complaints, vaginal atrophy, QoL [quality of life] and sexual function

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2014

At a glance

  • Drugs Tibolone (Primary) ; Estradiol/norethisterone
  • Indications Menopausal syndrome; Menopause
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Organon
  • Most Recent Events

    • 06 Oct 2009 Additional lead trial centre and sponsor (Schering-Plough) identified as reported by ClinicalTrials.gov.
    • 08 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top